Pharma, biotech, devices, and care delivery — listed healthcare ranked by market cap with daily prices and 1-year returns.
| # | Company | Market Cap | Price | 1D | 1Y | QL Signal |
|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co. LLY |
$1.0Tlarge | $1252 | +3.66% | +51.4% | Buy |
| 2 | Johnson & Johnson JNJ |
$651Blarge | $253 | -0.04% | +32.5% | Underweight |
| 3 | ABBVIE INC. ABBV |
$466Blarge | $283 | -0.26% | +25.3% | Buy |
| 4 | Merck & Co., Inc. MRK |
$362Blarge | $145 | -1.47% | +72.6% | Underweight |
| 5 | Novartis AG NVS |
$267Blarge | $150 | +2.38% | +15.7% | Buy |
| 6 | AstraZeneca PLC AZN |
$258Blarge | $167 | +2.87% | +96.5% | Buy |
| 7 | Thermo Fisher Scientific, Inc. TMO |
$241Blarge | $696 | +3.98% | +31.9% | Buy |
| 8 | KLA Corporation KLAC |
$231Blarge | $174 | -3.12% | +60.5% | Underweight |
| 9 | Amgen Inc AMGN |
$208Blarge | $434 | +1.85% | +46.0% | Buy |
| 10 | Novo-Nordisk A/S NVO |
$191Blarge | $39.22 | +3.12% | -30.8% | Buy |
| 11 | Gilead Sciences Inc GILD |
$186Blarge | $157 | +2.59% | +33.0% | Buy |
| 12 | Abbott Laboratories ABT |
$178Blarge | $105 | +1.66% | -19.1% | Buy |
| 13 | Pfizer Inc. PFE |
$158Blarge | $29.44 | +0.68% | +20.7% | Neutral |
| 14 | Danaher Corporation DHR |
$149Blarge | $232 | +3.03% | +12.3% | Buy |
| 15 | Intuitive Surgical Inc. ISRG |
$139Blarge | $428 | +1.69% | -1.8% | Buy |
| 16 | Vertex Pharmaceuticals Inc VRTX |
$129Blarge | $509 | +2.06% | +24.7% | Buy |
| 17 | Bristol-Myers Squibb Co. BMY |
$129Blarge | $60.57 | +2.56% | +38.9% | Neutral |
| 18 | Medtronic plc MDT |
$118Blarge | $95.45 | +1.29% | +0.1% | Buy |
| 19 | Stryker Corporation SYK |
$106Blarge | $293 | +4.12% | -20.7% | Buy |
| 20 | McKesson Corporation MCK |
$102Blarge | $999 | +1.89% | +26.1% | Buy |
| 21 | Sanofi SNY |
$102Blarge | $40.29 | +1.34% | -17.7% | Neutral |
| 22 | GSK plc GSK |
$101Blarge | $49.02 | +2.40% | +12.0% | Buy |
| 23 | Trane Technologies plc TT |
$94Blarge | $457 | -3.24% | +8.3% | Underweight |
| 24 | HCA Healthcare, Inc. HCA |
$93Blarge | $469 | -0.41% | +11.5% | Buy |
| 25 | 3M Company MMM |
$86Blarge | $165 | +0.53% | +7.7% | Neutral |
| 26 | Regeneron Pharmaceuticals Inc REGN |
$81Blarge | $796 | +2.31% | +38.2% | Buy |
| 27 | Boston Scientific Corp. BSX |
$63Blarge | $44.14 | +3.09% | -54.8% | Buy |
| 28 | Coherent Corp. COHR |
$62Blarge | $251 | -4.83% | +127.0% | Underweight |
| 29 | argenx SE ARGX |
$62Blarge | $846 | +3.42% | +3.8% | Neutral |
| 30 | Moderna, Inc. MRNA |
$61Blarge | $237 | +4.19% | +753.2% | Buy |
| 31 | Takeda Pharmaceutical Company Limited TAK |
$60Blarge | $19.45 | +2.31% | +40.3% | Underweight |
| 32 | Cencora, Inc. COR |
$59Blarge | $341 | +1.66% | +6.8% | Buy |
| 33 | Teradyne, Inc. TER |
$58Blarge | $343 | -5.41% | +143.4% | Underweight |
| 34 | Keysight Technologies, Inc. KEYS |
$57Blarge | $342 | -4.23% | +107.5% | Underweight |
| 35 | Ametek, Inc. AME |
$54Blarge | $249 | +0.68% | +33.8% | Neutral |
| 36 | Natera, Inc. NTRA |
$53Blarge | $405 | +3.48% | +125.6% | Buy |
| 37 | Cardinal Health, Inc. CAH |
$52Blarge | $254 | +2.41% | +63.0% | Buy |
| 38 | Edwards Lifesciences Corp EW |
$51Blarge | $88.10 | +1.91% | +20.8% | Buy |
| 39 | Becton, Dickinson and Co. BDX |
$49Blarge | $194 | +2.58% | +3.7% | Buy |
| 40 | Rockwell Automation, Inc. ROK |
$46Blarge | $422 | -0.33% | +19.9% | Underweight |
| 41 | Teva Pharmaceutical Industries Limited TEVA |
$45Blarge | $41.11 | +0.96% | +107.8% | Neutral |
| 42 | Agilent Technologies Inc. A |
$44Blarge | $176 | +0.89% | +25.7% | Buy |
| 43 | IQVIA Holdings Inc. IQV |
$44Blarge | $271 | +3.66% | +33.4% | Neutral |
| 44 | Waters Corp WAT |
$41Blarge | $444 | +1.73% | +33.6% | Neutral |
| 45 | Revolution Medicines, Inc. RVMD |
$41Blarge | $189 | -2.20% | +281.9% | Underweight |
| 46 | Idexx Laboratories Inc IDXX |
$40Blarge | $547 | +3.43% | -14.4% | Buy |
| 47 | BeOne Medicines Ltd. ONC |
$40Blarge | $374 | +6.43% | +18.3% | Buy |
| 48 | Roper Technologies, Inc. ROP |
$37Blarge | $382 | +2.62% | -23.5% | Buy |
| 49 | Illumina Inc ILMN |
$36Blarge | $268 | -0.65% | +188.1% | Underweight |
| 50 | DexCom, Inc. DXCM |
$34Blarge | $87.71 | +4.97% | +34.1% | Buy |
142 of the top 150 healthcare names by market cap, grouped into 5 clusters on seven daily features — 20-day momentum, RSI, the QL composite, 1-year and 6-month return, size and news sentiment. The layout is a principal-components projection of those features (42.5% + 17.6% of the variance), so distance on the map is similarity in the data, not a drawing. 8 ranked names lacked a feature and are left off rather than imputed. Hover a bubble or a cluster card; click a bubble for the stock page.
| Stock | Cluster | Market cap | 1Y | 20D | RSI | QL Signal |
|---|---|---|---|---|---|---|
| LLY Eli Lilly & Co. | Mega-cap core · overbought tape | $1.0T | +51.4% | +8.6% | 67.7 | Buy |
| JNJ Johnson & Johnson | Mega-cap core · overbought tape | $651B | +32.5% | -6.3% | 40.9 | Underweight |
| ABBV ABBVIE INC. | Mega-cap core · overbought tape | $466B | +25.3% | +7.3% | 69.4 | Buy |
| MRK Merck & Co., Inc. | Mega-cap core · overbought tape | $362B | +72.6% | -1.3% | 50.5 | Underweight |
| AZN AstraZeneca PLC | Mega-cap core · overbought tape | $258B | +96.5% | +0.3% | 58.8 | Buy |
| TMO Thermo Fisher Scientific, Inc. | Mega-cap core · overbought tape | $241B | +31.9% | +5.8% | 67.4 | Buy |
| AMGN Amgen Inc | Mega-cap core · overbought tape | $208B | +46.0% | +14.3% | 63.6 | Buy |
| GILD Gilead Sciences Inc | Mega-cap core · overbought tape | $186B | +33.0% | +4.3% | 66 | Buy |
| ABT Abbott Laboratories | Mega-cap core · overbought tape | $178B | -19.1% | +2.4% | 58.5 | Buy |
| PFE Pfizer Inc. | Mega-cap core · overbought tape | $158B | +20.7% | +6.5% | 68.4 | Neutral |
| DHR Danaher Corporation | Mega-cap core · overbought tape | $149B | +12.3% | +8.9% | 65.7 | Buy |
| ISRG Intuitive Surgical Inc. | Mega-cap core · overbought tape | $139B | -1.8% | +11.6% | 65.2 | Buy |
| VRTX Vertex Pharmaceuticals Inc | Mega-cap core · overbought tape | $129B | +24.7% | -1.5% | 48.3 | Buy |
| BMY Bristol-Myers Squibb Co. | Mega-cap core · overbought tape | $129B | +38.9% | -3.6% | 47.3 | Neutral |
| MDT Medtronic plc | Mega-cap core · overbought tape | $118B | +0.1% | +2.9% | 67 | Buy |
| SYK Stryker Corporation | Mega-cap core · overbought tape | $106B | -20.7% | +4.7% | 57.5 | Buy |
| MCK McKesson Corporation | Mega-cap core · overbought tape | $102B | +26.1% | +13.5% | 74.8 | Buy |
| TT Trane Technologies plc | Mega-cap core · overbought tape | $94B | +8.3% | +8.0% | 48.5 | Underweight |
| HCA HCA Healthcare, Inc. | Mega-cap core · overbought tape | $93B | +11.5% | +9.2% | 72 | Buy |
| MMM 3M Company | Mega-cap core · overbought tape | $86B | +7.7% | +0.4% | 49.9 | Neutral |
| REGN Regeneron Pharmaceuticals Inc | Mega-cap core · overbought tape | $81B | +38.2% | +0.9% | 59.3 | Buy |
| BSX Boston Scientific Corp. | Mega-cap core · overbought tape | $63B | -54.8% | +1.4% | 51.2 | Buy |
| AME Ametek, Inc. | Mega-cap core · overbought tape | $54B | +33.8% | +6.1% | 53.5 | Neutral |
| CAH Cardinal Health, Inc. | Mega-cap core · overbought tape | $52B | +63.0% | +12.1% | 73.9 | Buy |
| EW Edwards Lifesciences Corp | Mega-cap core · overbought tape | $51B | +20.8% | -0.2% | 54.3 | Buy |
| IQV IQVIA Holdings Inc. | Mega-cap core · overbought tape | $44B | +33.4% | +0.6% | 59.9 | Neutral |
| ROP Roper Technologies, Inc. | Mega-cap core · overbought tape | $37B | -23.5% | +2.1% | 58.5 | Buy |
| ZTS ZOETIS INC. | Mega-cap core · overbought tape | $30B | -44.8% | +7.4% | 67.4 | Buy |
| KLAC KLA Corporation | Oversold tape · momentum laggards | $231B | +60.5% | +3.2% | 35.9 | Underweight |
| COHR Coherent Corp. | Oversold tape · momentum laggards | $62B | +127.0% | -15.3% | 36.9 | Underweight |
| TER Teradyne, Inc. | Oversold tape · momentum laggards | $58B | +143.4% | -2.8% | 37 | Underweight |
| KEYS Keysight Technologies, Inc. | Oversold tape · momentum laggards | $57B | +107.5% | +3.2% | 41.6 | Underweight |
| ROK Rockwell Automation, Inc. | Oversold tape · momentum laggards | $46B | +19.9% | +2.9% | 40 | Underweight |
| RVMD Revolution Medicines, Inc. | Oversold tape · momentum laggards | $41B | +281.9% | -3.9% | 41.2 | Underweight |
| ROIV Roivant Sciences Ltd. Common Shares | Oversold tape · momentum laggards | $29B | +100.4% | -14.9% | 39.7 | Underweight |
| INSM Insmed, Inc. | Oversold tape · momentum laggards | $26B | -39.3% | -20.0% | 31.8 | Underweight |
| INCY Incyte Genomics Inc | Oversold tape · momentum laggards | $25B | +28.5% | -11.2% | 39.8 | Underweight |
| MKSI MKS Inc. | Oversold tape · momentum laggards | $17B | +67.5% | -4.9% | 32.2 | Underweight |
| JAZZ Jazz Pharmaceuticals, Inc. | Oversold tape · momentum laggards | $16B | +57.9% | -12.1% | 30.5 | Neutral |
| NBIX Neurocrine Biosciences Inc | Oversold tape · momentum laggards | $15B | -0.6% | -9.8% | 36.3 | Underweight |
| SMMT Summit Therapeutics Inc. | Oversold tape · momentum laggards | $14B | -32.1% | -13.3% | 42.7 | Underweight |
| ONTO Onto Innovation Inc. | Oversold tape · momentum laggards | $13B | +74.3% | -7.2% | 31.4 | Underweight |
| BMRN BioMarin Pharmaceuticals Inc | Oversold tape · momentum laggards | $12B | +5.6% | -13.9% | 35.4 | Neutral |
| MDGL Madrigal Pharmaceuticals, Inc. | Oversold tape · momentum laggards | $12B | +6.1% | -14.0% | 27.5 | Underweight |
| AXSM Axsome Therapeutics, Inc | Oversold tape · momentum laggards | $11B | +24.9% | -24.5% | 26.3 | Underweight |
| CGNX Cognex Corp | Oversold tape · momentum laggards | $10B | +21.6% | -8.5% | 37.6 | Underweight |
| KRYS Krystal Biotech, Inc. | Oversold tape · momentum laggards | $10.0B | +71.0% | -2.6% | 46.7 | Neutral |
| KYMR Kymera Therapeutics, Inc. | Oversold tape · momentum laggards | $9.8B | +72.0% | -8.7% | 43.1 | Neutral |
| CYTK Cytokinetics Inc. | Oversold tape · momentum laggards | $9.6B | +1.8% | -8.6% | 41.1 | Neutral |
| ARWR Arrowhead Research Corporation | Oversold tape · momentum laggards | $9.4B | +53.2% | -13.6% | 28.5 | Neutral |
| BRKR Bruker Corporation | Oversold tape · momentum laggards | $9.4B | +56.2% | -10.3% | 42.6 | Underweight |
| PRAX Praxis Precision Medicines, Inc. | Oversold tape · momentum laggards | $8.3B | +332.9% | -20.0% | 29.4 | Underweight |
| SYRE Spyre Therapeutics, Inc. | Oversold tape · momentum laggards | $8.0B | +261.0% | -13.6% | 39.6 | Neutral |
| IMVT Immunovant, Inc. | Oversold tape · momentum laggards | $7.6B | +53.4% | -26.9% | 14.3 | Underweight |
| IONS Ionis Pharmaceuticals, Inc. | Oversold tape · momentum laggards | $7.4B | -39.0% | -5.6% | 41.3 | Neutral |
| ALKS Alkermes Inc. plc | Oversold tape · momentum laggards | $7.3B | +24.4% | -14.1% | 37.8 | Neutral |
| RYTM Rhythm Pharmaceuticals, Inc. | Oversold tape · momentum laggards | $6.7B | -19.5% | -11.2% | 30.8 | Neutral |
| CGON CG Oncology, Inc. | Oversold tape · momentum laggards | $6.6B | +43.7% | -18.2% | 33.3 | Underweight |
| ORKA Oruka Therapeutics, Inc. | Oversold tape · momentum laggards | $6.3B | +164.7% | -24.4% | 30.5 | Underweight |
| MMED MiniMed Group, Inc. | Oversold tape · momentum laggards | $6.1B | 0.0% | -18.3% | 38.5 | Neutral |
| ST Sensata Technologies Holding plc | Oversold tape · momentum laggards | $6.1B | +29.3% | -2.2% | 43.6 | Buy |
| LQDA Liquidia Corporation | Oversold tape · momentum laggards | $6.0B | +50.2% | -49.1% | 36.1 | Buy |
| MIRM Mirum Pharmaceuticals, Inc. | Oversold tape · momentum laggards | $6.0B | +8.1% | -16.6% | 39.2 | Neutral |
| TVTX Travere Therapeutics, Inc. | Oversold tape · momentum laggards | $5.9B | +96.6% | -18.5% | 32.8 | Underweight |
| SRRK Scholar Rock Holding Corporation | Oversold tape · momentum laggards | $5.7B | +25.4% | -17.1% | 29.8 | Underweight |
| COGT Cogent Biosciences, Inc. | Oversold tape · momentum laggards | $5.5B | +78.1% | -11.1% | 38.5 | Neutral |
| PTCT PTC Therapeutics, Inc. | Oversold tape · momentum laggards | $5.5B | -11.0% | -10.3% | 37.9 | Underweight |
| MRNA Moderna, Inc. | Overbought tape · negative news flow | $61B | +753.2% | +49.6% | 71.7 | Buy |
| COR Cencora, Inc. | Overbought tape · negative news flow | $59B | +6.8% | +10.3% | 70.7 | Buy |
| NTRA Natera, Inc. | Overbought tape · negative news flow | $53B | +125.6% | +10.5% | 62 | Buy |
| BDX Becton, Dickinson and Co. | Overbought tape · negative news flow | $49B | +3.7% | +6.8% | 68.2 | Buy |
| A Agilent Technologies Inc. | Overbought tape · negative news flow | $44B | +25.7% | +12.3% | 68.2 | Buy |
| WAT Waters Corp | Overbought tape · negative news flow | $41B | +33.6% | +3.4% | 61.5 | Neutral |
| IDXX Idexx Laboratories Inc | Overbought tape · negative news flow | $40B | -14.4% | +8.0% | 61.2 | Buy |
| RMD ResMed Inc. | Overbought tape · negative news flow | $32B | -10.2% | +6.1% | 73.4 | Buy |
| BIIB Biogen Inc. | Overbought tape · negative news flow | $32B | +63.8% | +7.4% | 66 | Buy |
| GEHC GE HealthCare Technologies Inc. | Overbought tape · negative news flow | $29B | -3.9% | +9.2% | 64.9 | Buy |
| MTD Mettler-Toledo International | Overbought tape · negative news flow | $28B | +25.7% | +16.2% | 75.9 | Buy |
| MDLN Medline Inc. | Overbought tape · negative news flow | $28B | 0.0% | +13.9% | 61.1 | Buy |
| DGX Quest Diagnostics Inc. | Overbought tape · negative news flow | $27B | +27.7% | -3.3% | 57.2 | Buy |
| LH Labcorp Holdings Inc. | Overbought tape · negative news flow | $26B | +15.0% | +0.7% | 62.4 | Buy |
| VLTO Veralto Corporation | Overbought tape · negative news flow | $23B | -0.9% | +6.0% | 68.3 | Buy |
| STE STERIS plc | Overbought tape · negative news flow | $20B | -5.2% | +7.8% | 65.5 | Buy |
| VTRS Viatris Inc. | Overbought tape · negative news flow | $19B | +82.6% | +6.4% | 64.4 | Buy |
| RVTY Revvity, Inc. | Overbought tape · negative news flow | $16B | +67.9% | +5.4% | 63.2 | Neutral |
| EXEL Exelixis Inc | Overbought tape · negative news flow | $14B | +57.0% | +7.4% | 72.1 | Buy |
| ULS UL Solutions Inc. | Overbought tape · negative news flow | $13B | -3.8% | +15.5% | 65.4 | Buy |
| HALO Halozyme Therapeutics, Inc. | Overbought tape · negative news flow | $13B | +83.1% | +10.8% | 70.1 | Buy |
| EHC Encompass Health Corporation | Overbought tape · negative news flow | $12B | +3.3% | +3.8% | 65.6 | Neutral |
| BAX Baxter International Inc. | Overbought tape · negative news flow | $12B | +13.2% | +11.9% | 66 | Buy |
| AVTR Avantor, Inc. | Overbought tape · negative news flow | $10B | +16.0% | +1.5% | 64.8 | Neutral |
| UHS Universal Health Services, Inc. | Overbought tape · negative news flow | $10B | -8.6% | +3.7% | 68.9 | Buy |
| GMED GLOBUS MEDICAL INC | Overbought tape · negative news flow | $9.9B | +35.2% | +6.3% | 60 | Buy |
| IBRX ImmunityBio, Inc. | Overbought tape · negative news flow | $9.0B | +287.6% | +18.2% | 59.5 | Buy |
| TGTX TG Therapeutics, Inc. | Overbought tape · negative news flow | $8.7B | +59.8% | -0.8% | 54.8 | Buy |
| CAI Caris Life Sciences, Inc. | Overbought tape · negative news flow | $8.5B | +1.9% | +2.7% | 62.7 | Buy |
| PACS PACS Group, Inc. | Overbought tape · negative news flow | $6.7B | +276.3% | +13.5% | 71.5 | Buy |
| CHE Chemed Corporation | Overbought tape · negative news flow | $6.6B | +18.1% | +1.9% | 56.1 | Buy |
| HIMS Hims & Hers Health, Inc. | Overbought tape · negative news flow | $6.5B | -53.2% | +5.3% | 50.2 | Buy |
| KNSA Kiniksa Pharmaceuticals International, plc | Overbought tape · negative news flow | $6.0B | +105.7% | +0.8% | 60.9 | Neutral |
| BLCO Bausch + Lomb Corporation | Overbought tape · negative news flow | $6.0B | +11.3% | -0.7% | 46.5 | Buy |
| DXCM DexCom, Inc. | Positive news flow · small-cap fringe | $34B | +34.1% | -0.2% | 55.2 | Buy |
| ALNY Alnylam Pharmaceuticals, Inc. | Positive news flow · small-cap fringe | $32B | -50.2% | -4.7% | 48.2 | Neutral |
| RPRX Royalty Pharma plc | Positive news flow · small-cap fringe | $26B | +64.8% | +1.2% | 57.6 | Buy |
| WST West Pharmaceutical Services, Inc. | Positive news flow · small-cap fringe | $25B | +45.7% | +4.5% | 64.5 | Buy |
| PHG KONINKLIJKE PHILIPS N.V. | Positive news flow · small-cap fringe | $24B | -8.3% | +3.3% | 59.3 | Buy |
| UTHR United Therapeutics Corp | Positive news flow · small-cap fringe | $21B | +25.3% | +8.9% | 56.8 | Buy |
| THC Tenet Healthcare Corporation New | Positive news flow · small-cap fringe | $21B | +38.1% | +5.1% | 66 | Buy |
| ZBH Zimmer Biomet Holdings, Inc. | Positive news flow · small-cap fringe | $18B | -5.0% | +0.1% | 55.8 | Buy |
| MEDP Medpace Holdings, Inc. | Positive news flow · small-cap fringe | $17B | +22.2% | +2.2% | 58.6 | Buy |
| FTV Fortive Corporation | Positive news flow · small-cap fringe | $17B | +19.2% | +4.9% | 54.5 | Buy |
| SOLV Solventum Corporation | Positive news flow · small-cap fringe | $15B | +22.8% | +0.4% | 50.6 | Neutral |
| TRMB Trimble Inc. | Positive news flow · small-cap fringe | $13B | -22.5% | +6.4% | 60.1 | Buy |
| CRL Charles River Laboratories International, Inc. | Positive news flow · small-cap fringe | $13B | +79.4% | +8.7% | 61.1 | Buy |
| BBIO BridgeBio Pharma, Inc. | Positive news flow · small-cap fringe | $13B | +18.5% | -0.3% | 46.5 | Buy |
| PEN Penumbra, Inc. | Positive news flow · small-cap fringe | $13B | +27.2% | +0.7% | 58.2 | Neutral |
| DVA DaVita Inc. | Positive news flow · small-cap fringe | $12B | +50.1% | +3.3% | 60.6 | Buy |
| TECH Bio-Techne Corp. | Positive news flow · small-cap fringe | $11B | +21.7% | +0.2% | 54.2 | Neutral |
| BTSG BrightSpring Health Services, Inc. | Positive news flow · small-cap fringe | $11B | +102.9% | +10.2% | 56.6 | Neutral |
| ELAN Elanco Animal Health Incorporated | Positive news flow · small-cap fringe | $11B | +14.8% | +3.5% | 58.1 | Buy |
| COO The Cooper Companies, Inc. | Positive news flow · small-cap fringe | $11B | -16.5% | +6.7% | 47.9 | Buy |
| ALGN Align Technology Inc | Positive news flow · small-cap fringe | $10B | +16.3% | -0.2% | 53 | Buy |
| ENSG The Ensign Group, Inc. | Positive news flow · small-cap fringe | $10B | +0.1% | +1.8% | 59.2 | Buy |
| BIO Bio-Rad Laboratories, Inc. | Positive news flow · small-cap fringe | $10B | +19.3% | -4.6% | 46.5 | Underweight |
| RGEN Repligen Corp | Positive news flow · small-cap fringe | $10.0B | +23.2% | +3.4% | 55.3 | Buy |
| PODD Insulet Corporation | Positive news flow · small-cap fringe | $9.8B | -55.6% | -2.0% | 51.9 | Buy |
| GKOS Glaukos Corporation | Positive news flow · small-cap fringe | $9.7B | +93.5% | +2.6% | 49.6 | Buy |
| HSIC Henry Schein Inc | Positive news flow · small-cap fringe | $9.5B | +37.5% | +2.3% | 55.3 | Buy |
| PTGX Protagonist Therapeutics, Inc | Positive news flow · small-cap fringe | $9.3B | +75.8% | -5.0% | 40.7 | Neutral |
| PCVX Vaxcyte, Inc. | Positive news flow · small-cap fringe | $8.7B | +48.5% | +8.1% | 53.6 | Underweight |
| RAL Ralliant Corporation | Positive news flow · small-cap fringe | $7.5B | +59.1% | +2.1% | 45.6 | Underweight |
| MSA Mine Safety Incorporated | Positive news flow · small-cap fringe | $6.9B | +8.6% | +1.7% | 50.3 | Buy |
| LNTH Lantheus Holdings, Inc | Positive news flow · small-cap fringe | $6.6B | +76.9% | -0.8% | 45 | Neutral |
| AMRX Amneal Pharmaceuticals, Inc. | Positive news flow · small-cap fringe | $6.5B | +96.8% | +5.3% | 49.6 | Buy |
| RDNT RadNet, Inc. | Positive news flow · small-cap fringe | $6.0B | -8.3% | -9.5% | 47.4 | Buy |
| LGND Ligand Pharmaceuticals Inc. | Positive news flow · small-cap fringe | $5.7B | +62.9% | +4.9% | 50.6 | Buy |
| CRSP CRISPR Therapeutics AG | Positive news flow · small-cap fringe | $5.5B | -28.3% | -10.1% | 44.2 | Buy |
| ILMN Illumina Inc | Six-month runners · past-year winners | $36B | +188.1% | +9.3% | 56.4 | Underweight |
| GH Guardant Health, Inc. | Six-month runners · past-year winners | $24B | +158.4% | -9.4% | 45.9 | Underweight |
| CORT Corcept Therapeutics Inc. | Six-month runners · past-year winners | $12B | +47.6% | -1.3% | 45.4 | Underweight |
| TWST Twist Bioscience Corporation | Six-month runners · past-year winners | $11B | +351.0% | -7.1% | 43 | Underweight |
| TXG 10x Genomics, Inc. | Six-month runners · past-year winners | $10.0B | +508.8% | -5.9% | 44.9 | Underweight |
Which major wrappers carry this ranking — counted over 18 curated funds (sector SPDRs + broad-market index funds), not every ETF in existence. The full stock ↔ ETF passive-flow map is at Equities Network.
The largest listed healthcare companies by market cap are Eli Lilly & Co. ($1.0T), Johnson & Johnson ($651B), ABBVIE INC. ($466B), Merck & Co., Inc. ($362B), Novartis AG ($267B). The full ranking of 884 stocks refreshes daily at quantlogix.ai/public/healthcare.
Among the top-50 healthcare stocks by market cap, the best 1-year returns are Moderna, Inc. (+753.2%), Revolution Medicines, Inc. (+281.9%), Illumina Inc (+188.1%), measured to 2026-10-15. Past performance does not predict future results.
Among 18 curated major wrappers, the funds holding the most of the top 50 healthcare stocks are IVV (50), SPY (50), VOO (50). Full map: Equities Network.
142 of the top 150 healthcare names are grouped by a seeded k-means over seven daily features (20-day momentum, RSI, the QL composite, 1-year and 6-month return, size, news sentiment) into 5 clusters: Mega-cap core · overbought tape (28); Oversold tape · momentum laggards (39); Overbought tape · negative news flow (34); Positive news flow · small-cap fringe (36); Six-month runners · past-year winners (5). The map is a principal-components projection of the same features. Clusters describe the tape today, not a forecast.
Market caps, prices, and day changes come from the daily universe build (last refreshed 2026-10-16 05:37); 1-year returns come from the performance-rankings build (measured to 2026-10-15). A stock without a price or return history says so rather than showing zero.
Methodology. Rankings are by market capitalization from the daily universe build (last refreshed 2026-10-16 05:37) — prices and day changes carry the same stamp, not live quotes. 1-year returns come from the performance-rankings build (measured to 2026-10-15); a stock without return history says so. The QL Signal is the QuantLogix 5-factor composite — an educational read on technical posture, not investment advice. The cluster map groups the ranked names by a deterministic k-means over seven standardized daily features and lays them out by principal components; clusters are named from their centroid's strongest traits and describe the tape today, not a forecast. Every row links to the full stock page with signals, fundamentals, and news.